Exploration of severe Covid-19 associated risk factor in China: Meta-analysis of current evidence

Int J Clin Pract. 2021 Dec;75(12):e14900. doi: 10.1111/ijcp.14900. Epub 2021 Oct 5.

Abstract

Aim: This meta-analysis aimed to explore potential risk factors for severe Covid-19.

Methods: We systemically and comprehensively retrieved the eligible study evaluating clinical differences between severe vs non-severe Covid-19. Main effect sizes were demographic characteristics, comorbidities, signs and symptoms, laboratory findings as well as radiological features of chest CT.

Results: A total of 2566 Covid-19 people (771 in the severe group and 1795 in the non-severe group) from 14 studies were eligible for this meta-analysis. It was demonstrated that older age and males were more likely to have severe Covid-19. Patients with underlying comorbidities, such as hypertension, diabetes, heart disease and COPD were significantly more susceptible to severe Covid-19. Patients with dyspnoea were more likely to be severely ill. Depressed total lymphocytes were observed in this article. Meanwhile, although reticulation (30.8%), intrathoracic lymph node enlargement (20.5%) and pleural effusions (30.8%) were relatively infrequent, meta-analysis revealed that patients with these presentations in chest CT were associated with increased risk of severe Covid-19.

Conclusions: There are significant differences in clinical characteristics between the severe and non-severe Covid-19 patients. Many factors are related to the severity of the disease, which can help clinicians to differentiate severe patients from non-severe patients.

Publication types

  • Meta-Analysis

MeSH terms

  • Aged
  • COVID-19*
  • China / epidemiology
  • Comorbidity
  • Humans
  • Male
  • Retrospective Studies
  • Risk Factors
  • SARS-CoV-2
  • Tomography, X-Ray Computed